Developer docs
API playgroundTry for free, no card

Search company profiles

Peptyde Bio

Full company profile

uuid0005a4z

Namestring
Peptyde Bio
Legal namestring
Peptyde Bio
Websiteurl
peptydebio.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Peptyde Bio was an agtech startup founded in 2022 as the first company spun out from the Donald Danforth Plant Science Center in St. Louis, Missouri. The company discovered, designed, and characterized novel antimicrobial peptides (AMPs) intended as biological alternatives or complements to chemical fungicides for crop protection, addressing sustainability concerns around traditional pesticide use in vegetables, row crops, and perennials. Its technology platform rested on more than 20 years of antimicrobial peptide research conducted by Danforth Center scientists Dilip Shah, PhD and Kirk Czymmek, PhD, and produced a pipeline of peptide lead candidates with novel modes of action against crop pests and diseases.

The company's business model was pre-commercial. Peptyde Bio raised approximately $1.45 million in external capital — a $1.2 million oversubscribed Pre-Seed round in November 2022 from Danforth Technology Company, St. Louis Arch Angels, BioGenerator Ventures, and QRM Capital, plus up to $250,000 in non-dilutive funding through the Wells Fargo Innovation Incubator (IN2) 11th cohort. The intended go-to-market was enterprise B2B field sales of biological peptide products to commercial agricultural growers, but no commercial revenue, pricing, or named customer relationships were disclosed.

On December 7, 2023, Peptyde Bio was acquired by Invaio Sciences, a Flagship Pioneering-founded bio platform company. The acquisition brought Peptyde Bio's peptide platform and IP portfolio into Invaio's AI/ML-enabled Discovery Engine and Biological Delivery Systems, accelerating Invaio's nature-positive crop protection pipeline. The transaction represented the first exit for a Danforth Technology Company portfolio company, validating the Danforth Center's startup-spinout strategy.

Short descriptiontext

Peptyde Bio was a St. Louis-based agtech startup developing antimicrobial peptide (AMP) alternatives to chemical fungicides for crop protection, founded on 20 years of Danforth Center research and acquired by Invaio Sciences in December 2023.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antimicrobial peptides, biological crop protection, sustainable agriculture, agricultural biotechnology, peptide discovery
Industry2 codes
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code3 codes
  • Pesticide and Other Agricultural Chemical Manufacturing325320
  • Pesticide and Other Agricultural Chemical Manufacturing32532
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Agricultural Chemicals2870
  • Biological Products, (No Disgnostic Substances)2836
Product category
Agricultural Biotechnology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biological Peptide Products for Crop Protection
TypeOne Time License
Description

Peptyde Bio developed and commercialized biological peptide solutions that protect crops from pests and diseases. These environmentally friendly peptides were positioned as alternatives or complements to chemical fungicides for agricultural growers. As a pre-commercial stage company acquired by Invaio Sciences in December 2023, the revenue model was in development stage.

invaio.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Peptyde Bio discovered, designed, and characterized novel antimicrobial peptides (AMPs) for use in agricultural crop protection. The company's technology produced a pipeline of biologically active peptides with novel modes of action that can complement or replace chemical fungicides for protecting crops from pests and diseases. These peptides were positioned as effective, environmentally friendly, and lower-cost alternatives to traditional fungicides for vegetables, row crops, and perennial crops.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Lower cost of development compared to traditional chemical fungicides
+1 more record
Product overview1 text field

Peptyde Bio was an agtech startup that discovered, designed, and characterized novel antimicrobial peptides for agricultural applications. The company operated as a technology platform with a pipeline of peptide lead candidates developed over 20 years of research. Following its acquisition by Invaio Sciences in December 2023, this technology and IP portfolio was integrated into Invaio's AI/ML-enabled Discovery Engine and Biological Delivery Systems to accelerate nature-positive crop protection solutions.

Product and service1 record
1Antimicrobial Peptide Technology Platform
CategoryCore Technology Platform
Description

A peptide discovery, design, and characterization platform for developing novel antimicrobial peptides for sustainable agricultural crop protection. The platform identifies biologically active peptides that protect crops from pests and diseases with lower environmental impact compared to traditional chemical fungicides. Targeted at commercial agricultural growers seeking sustainable alternatives to chemical crop protection in vegetables, row crops, and perennials.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-12-07
Description

Invaio Sciences acquired Peptyde Bio in December 2023 to accelerate its nature-positive crop protection pipeline. The acquisition brings Peptyde Bio's portfolio of confirmed peptide lead candidates and established platform and IP to Invaio's AI/ML-enabled discovery platform and delivery systems. This was the first exit for Danforth Technology Company.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Invaio Sciences acquired Peptyde Bio in December 2023 and is the direct commercial home for the peptide platform. It is a Flagship Pioneering-founded bio platform company developing nature-positive crop protection solutions across tree, vegetable, and row crops, making it the most directly comparable player.

TypeDirect peer
Description

AgBiome discovers and develops microbial and biological crop protection products (including biological fungicides and insecticides) using a microbiome-driven discovery platform. It competes directly with Peptyde Bio in the biological crop protection space targeting similar growers.

TypeDirect peer
Description

Pivot Bio develops microbial nitrogen-fixing crop nutrition products that replace synthetic fertilizers. It is a peer in the broader biological crop input category pursuing sustainable alternatives to conventional agrochemicals for row crop growers.

TypeBroad incumbent
Description

Indigo Ag uses microbial seed treatments and biological products to improve crop yield and sustainability. It operates across multiple row crops with a broader portfolio, making it a comparable broad incumbent in biological agriculture.

TypeDirect peer
Description

NewLeaf Symbiotics develops pink pigmented facultative methylotrophs (PPFMs) as biological solutions for crop health, including biocontrol and plant health products. It is a direct peer in the biological crop protection category.

TypeDirect peer
Description

BioConsortia discovers microbial consortia for nitrogen fixation, biocontrol, and yield improvement. It is comparable as a microbial and biological discovery platform targeting similar row crop and specialty crop growers.

TypeDirect peer
Description

Sound Agriculture develops on-demand nitrogen and biocontrol products using microbial and chemistry approaches for sustainable crop production. It is comparable in biological crop inputs and sustainability positioning.

TypeEmerging player
Description

Concentric Ag develops biological crop inputs leveraging peptide and protein-based technologies for nutrient use efficiency and crop protection. It is a focused emerging player in the peptide-based crop biology space adjacent to Peptyde Bio's technology.

TypeBroad incumbent
Description

Bayer's Crop Science division operates a large biological crop protection portfolio alongside its chemical and seed businesses. As a broad incumbent, it competes for the same grower demand for sustainable alternatives to chemical fungicides.

10Donald Danforth Plant Science Center
TypeOthers
Description

The Donald Danforth Plant Science Center is the research institution where Peptyde Bio's founding AMP technology was developed over 20 years. It functions as an enabling ecosystem participant, spinning out the company via its Danforth Technology Company subsidiary.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Peptyde Bio

Agricultural Biotechnologypeptydebio.com

Peptyde Bio was a St. Louis-based agtech startup developing antimicrobial peptide (AMP) alternatives to chemical fungicides for crop protection, founded on 20 years of Danforth Center research and acquired by Invaio Sciences in December 2023.

What Peptyde Bio does

Peptyde Bio was an agtech startup founded in 2022 as the first company spun out from the Donald Danforth Plant Science Center in St. Louis, Missouri. The company discovered, designed, and characterized novel antimicrobial peptides (AMPs) intended as biological alternatives or complements to chemical fungicides for crop protection, addressing sustainability concerns around traditional pesticide use in vegetables, row crops, and perennials. Its technology platform rested on more than 20 years of antimicrobial peptide research conducted by Danforth Center scientists Dilip Shah, PhD and Kirk Czymmek, PhD, and produced a pipeline of peptide lead candidates with novel modes of action against crop pests and diseases.

The company's business model was pre-commercial. Peptyde Bio raised approximately $1.45 million in external capital — a $1.2 million oversubscribed Pre-Seed round in November 2022 from Danforth Technology Company, St. Louis Arch Angels, BioGenerator Ventures, and QRM Capital, plus up to $250,000 in non-dilutive funding through the Wells Fargo Innovation Incubator (IN2) 11th cohort. The intended go-to-market was enterprise B2B field sales of biological peptide products to commercial agricultural growers, but no commercial revenue, pricing, or named customer relationships were disclosed.

On December 7, 2023, Peptyde Bio was acquired by Invaio Sciences, a Flagship Pioneering-founded bio platform company. The acquisition brought Peptyde Bio's peptide platform and IP portfolio into Invaio's AI/ML-enabled Discovery Engine and Biological Delivery Systems, accelerating Invaio's nature-positive crop protection pipeline. The transaction represented the first exit for a Danforth Technology Company portfolio company, validating the Danforth Center's startup-spinout strategy.

Peptyde Bio firmographics

Firmographics
Name
Peptyde Bio
Legal name
Peptyde Bio
Website
https://peptydebio.com
Company type
Private
Founded year
2022
Operating status
Acquired
Headcount range
1–10 employees
Short description
Peptyde Bio was a St. Louis-based agtech startup developing antimicrobial peptide (AMP) alternatives to chemical fungicides for crop protection, founded on 20 years of Danforth Center research and acquired by Invaio Sciences in December 2023.
Ownership category
akta.pro rank

Peptyde Bio industry classification

Industry
Product category
Agricultural Biotechnology
NAICS
Pesticide and Other Agricultural Chemical Manufacturing (325320), Pesticide and Other Agricultural Chemical Manufacturing (32532), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Agricultural Chemicals (2870), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Antimicrobial peptides
  • Biological crop protection
  • Sustainable agriculture
  • Agricultural biotechnology
  • Peptide discovery

Where Peptyde Bio is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Peptyde Bio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Biological Peptide Products for Crop Protection: Peptyde Bio developed and commercialized biological peptide solutions that protect crops from pests and diseases. These environmentally friendly peptides were positioned as alternatives or complements to chemical fungicides for agricultural growers. As a pre-commercial stage company acquired by Invaio Sciences in December 2023, the revenue model was in development stage.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Peptyde Bio product offering

Product offering

Core offering

Peptyde Bio discovered, designed, and characterized novel antimicrobial peptides (AMPs) for use in agricultural crop protection. The company's technology produced a pipeline of biologically active peptides with novel modes of action that can complement or replace chemical fungicides for protecting crops from pests and diseases. These peptides were positioned as effective, environmentally friendly, and lower-cost alternatives to traditional fungicides for vegetables, row crops, and perennial crops.

Product overview

Peptyde Bio was an agtech startup that discovered, designed, and characterized novel antimicrobial peptides for agricultural applications. The company operated as a technology platform with a pipeline of peptide lead candidates developed over 20 years of research. Following its acquisition by Invaio Sciences in December 2023, this technology and IP portfolio was integrated into Invaio's AI/ML-enabled Discovery Engine and Biological Delivery Systems to accelerate nature-positive crop protection solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antimicrobial Peptide Technology Platform A peptide discovery, design, and characterization platform for developing novel antimicrobial peptides for sustainable agricultural crop protection. The platform identifies biologically active peptides that protect crops from pests and diseases with lower environmental impact compared to traditional chemical fungicides. Targeted at commercial agricultural growers seeking sustainable alternatives to chemical crop protection in vegetables, row crops, and perennials.

Quantifiable outcome

  • Lower cost of development compared to traditional chemical fungicides
  • +1 more outcomes

Companies that use Peptyde Bio

Customer profile

Segments1 record

Ideal customer profiles1 record

Peptyde Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Peptyde Bio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Invaio SciencesflagshipStrategic or Co-development Partner · 7 December 2023Invaio Sciences acquired Peptyde Bio in December 2023 to accelerate its nature-positive crop protection pipeline. The acquisition brings Peptyde Bio's portfolio of confirmed peptide lead candidates and established platform and IP to Invaio's AI/ML-enabled discovery platform and delivery systems. This was the first exit for Danforth Technology Company.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Peptyde Bio competitors and assessment

Company assessment

Broad incumbents

  • Invaio Sciences: Invaio Sciences acquired Peptyde Bio in December 2023 and is the direct commercial home for the peptide platform. It is a Flagship Pioneering-founded bio platform company developing nature-positive crop protection solutions across tree, vegetable, and row crops, making it the most directly comparable player.
  • Indigo Ag: Indigo Ag uses microbial seed treatments and biological products to improve crop yield and sustainability. It operates across multiple row crops with a broader portfolio, making it a comparable broad incumbent in biological agriculture.
  • Bayer Crop Science (Biologics): Bayer's Crop Science division operates a large biological crop protection portfolio alongside its chemical and seed businesses. As a broad incumbent, it competes for the same grower demand for sustainable alternatives to chemical fungicides.

Direct peers

  • AgBiome: AgBiome discovers and develops microbial and biological crop protection products (including biological fungicides and insecticides) using a microbiome-driven discovery platform. It competes directly with Peptyde Bio in the biological crop protection space targeting similar growers.
  • Pivot Bio: Pivot Bio develops microbial nitrogen-fixing crop nutrition products that replace synthetic fertilizers. It is a peer in the broader biological crop input category pursuing sustainable alternatives to conventional agrochemicals for row crop growers.
  • NewLeaf Symbiotics: NewLeaf Symbiotics develops pink pigmented facultative methylotrophs (PPFMs) as biological solutions for crop health, including biocontrol and plant health products. It is a direct peer in the biological crop protection category.
  • BioConsortia: BioConsortia discovers microbial consortia for nitrogen fixation, biocontrol, and yield improvement. It is comparable as a microbial and biological discovery platform targeting similar row crop and specialty crop growers.
  • Sound Agriculture: Sound Agriculture develops on-demand nitrogen and biocontrol products using microbial and chemistry approaches for sustainable crop production. It is comparable in biological crop inputs and sustainability positioning.

Emerging players

  • Concentric Ag: Concentric Ag develops biological crop inputs leveraging peptide and protein-based technologies for nutrient use efficiency and crop protection. It is a focused emerging player in the peptide-based crop biology space adjacent to Peptyde Bio's technology.

Others

  • Donald Danforth Plant Science Center: The Donald Danforth Plant Science Center is the research institution where Peptyde Bio's founding AMP technology was developed over 20 years. It functions as an enabling ecosystem participant, spinning out the company via its Danforth Technology Company subsidiary.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Peptyde Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Peptyde Bio leadership team

Management profile

Number of profiles

Profiles1 record

Peptyde Bio funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Peptyde Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Peptyde Bio

What does Peptyde Bio do?

Peptyde Bio discovered, designed, and characterized novel antimicrobial peptides (AMPs) for use in agricultural crop protection. The company's technology produced a pipeline of biologically active peptides with novel modes of action that can complement or replace chemical fungicides for protecting crops from pests and diseases. These peptides were positioned as effective, environmentally friendly, and lower-cost alternatives to traditional fungicides for vegetables, row crops, and perennial crops.

Is Peptyde Bio a public or private company?

Peptyde Bio is a private company. It is classified as corporate owned and is currently acquired.

When was Peptyde Bio founded?

Peptyde Bio was founded in 2022. It employs 1 to 10 people.

Where is Peptyde Bio based?

Peptyde Bio is headquartered in St Louis, United States, in the North America region.

How does Peptyde Bio make money?

One revenue line is on record: biological Peptide Products for Crop Protection.

Who are Peptyde Bio's main competitors?

Broad incumbents on record are Invaio Sciences, Indigo Ag and Bayer Crop Science (Biologics). Direct peers are AgBiome, Pivot Bio, NewLeaf Symbiotics, BioConsortia and Sound Agriculture. Concentric Ag is listed as an emerging player. Donald Danforth Plant Science Center is listed as an others.

Does Peptyde Bio have an API?

No public API is recorded for Peptyde Bio.

What industry is Peptyde Bio in?

Peptyde Bio's product category is Agricultural Biotechnology. Its primary akta.pro industry code is AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial), with a secondary code of AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine). Its NAICS code is 325320 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsPeptyde Bio validates Danforth Center investment strategy: Fire Awards 2024Peptyde Bio, a Danforth Center startup developing natural fungicides, was acquired in December 2023 by Invaio Sciences, marking the first startup exit for Danforth Technology Co. The acquisition combines Peptyde's peptides with Invaio's delivery systems, and Invaio plans to field test its lead candidate in 2024.FinSMEsInvaio Sciences Acquires Peptyde BioInvaio Sciences acquired Peptyde Bio, a Cambridge, MA-based company that discovers and designs novel peptides for agriculture. The deal amount was not disclosed. The acquisition adds an established platform and IP portfolio to accelerate peptide discovery for sustainable crop protection.American City Business JournalsAgtech startup, spun out of Danforth Center, acquired by Boston-area firmInvaio Sciences, a Cambridge-based firm, acquired Peptyde Bio, a St. Louis-based agtech startup developing natural fungicides, on Thursday. Financial terms were not disclosed. The deal marks the first startup exit for Danforth Technology Co., a subsidiary of the Danforth Center.PR NewswireInvaio Sciences acquires Peptyde Bio to accelerate nature-positive crop protection pipelineInvaio Sciences acquired Peptyde Bio, a company that discovers and designs novel peptides for agriculture. The acquisition adds Peptyde Bio's confirmed peptide lead candidates to Invaio's pipeline, aiming to accelerate sustainable crop protection with lower pesticide and water use.InvaioInvaio Sciences acquires Peptyde Bio to accelerate nature-positive crop protection pipelineInvaio Sciences has acquired Peptyde Bio to integrate its peptide discovery platform and IP portfolio into Invaio's AI-enabled crop protection pipeline. This strategic move aims to accelerate the development of nature-positive biological actives that reduce pesticide use while maintaining crop health. The acquisition marks the first exit for a company launched by the Danforth Technology Company.AgriBusiness GlobalInvaio Sciences Acquires Peptyde Bio to Accelerate Nature-Positive Crop Protection PipelineInvaio Sciences has acquired Peptyde Bio, a company specializing in the discovery and design of novel peptides for agricultural use, to accelerate its nature-positive crop protection pipeline. This acquisition integrates Peptyde Bio’s IP portfolio into Invaio’s AI-driven discovery engine and biological delivery systems to develop sustainable pest and disease control solutions. The deal marks the first exit for a startup incubated by the Danforth Technology Company.American City Business JournalsStartups to Watch 2023: Peptyde Bio creates template for spinning more startups out of Donald Danforth Plant Science CenterPeptyde Bio has been established as the inaugural startup launched by Danforth Technology Corp., an entity dedicated to commercializing research from the Donald Danforth Plant Science Center. This initiative serves as a model for the center's broader strategy to generate additional spin-off companies from its campus. The article notes that full details are restricted to premium subscribers.Danforthcenter(St. Louis Inno) 3 St. Louis startups win spots in Danforth Center/Wells Fargo agtech incubator programThe Danforth Center and Wells Fargo announced the fourth cohort of their agtech incubator program, selecting three startups from St. Louis to participate. The selected companies—Edison Agrosciences, Peptyde Bio, and Synthetic Vector Design LLC—focus on biological solutions to enhance global food system resilience. This selection highlights the region's growing involvement in sustainable agriculture technology.